Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Health GroupFRA:VNL1 42 Market Cap is €8.82 Mil as of Aug. 26, 2026. GuruFocus rates FRA:VNL1 with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, China Health Group ranks worse than 81.48% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). China Health Group's share price for the quarter that ended in Dec. 2025 was €0.006. China Health Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 995.35 Mil. Therefore, China Health Group's market cap for the quarter that ended in Dec. 2025 was €5.97 Mil.
China Health Group's quarterly market cap
declined
from Dec. 2024 (€11.94 Mil) to Jun. 2025 (€7.96 Mil) and
declined
from Jun. 2025 (€7.96 Mil) to Dec. 2025 (€5.97 Mil).
China Health Group's annual market cap
increased
from Dec. 2023 (€4.98 Mil) to Dec. 2024 (€11.94 Mil) but then
declined
from Dec. 2024 (€11.94 Mil) to Dec. 2025 (€5.97 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. China Health Group's Enterprise Value for Today is €5.50 Mil.
China Health Group (FRA:VNL1) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
China Health Group Market Cap Related Terms
China Health Group Market Cap Historical Data
* Premium members only.
The historical data trend for China Health Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, China Health Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Group Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, China Health Group's Market Cap distribution charts can be found below:
* The bar in red indicates where China Health Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
China Health Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Group (FRA:VNL1) has a Market Cap of €8.82 Mil as of Aug. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on China Health Group and its competitors. According to the industry distribution chart, China Health Group ranks #176 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 81.5%.
Is China Health Group's Market Cap too high?
China Health Group's current Market Cap is €8.82 Mil. Based on the distribution chart, China Health Group ranks #176 out of 216 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, China Health Group has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does China Health Group's Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, China Health Group ranks #176 out of 216 companies for Market Cap. This places China Health Group in the lower half of its industry. The industry median Market Cap is 63.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 63.27, based on 216 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on China Health Group and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 63.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Group's current Market Cap is €8.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Group stock overvalued right now?
China Health Group (FRA:VNL1) has a current Market Cap of €8.82 Mil. The current Market Cap is €8.82 Mil. China Health Group's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For China Health Group (FRA:VNL1), the current Market Cap is €8.82 Mil as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China Health Group Inc is an investment holding company engaged in providing medical care facilities in the People's Republic of China. The company provides provision of post-launch market research, medical and medical market services (PM services), Provision of contracted pharmaceutical development services (PD services), Provision of contracted clinical research services (CR Services), drug technologies, and Other medical services. The majority of its revenue for the company comes from the provision of PM services.
42GF Score
Get the complete analysis for FRA:VNL1
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VNL1 has been successfully added to your 
